Skip to content

BOSTON DR LIM

  • Home
  • 보스턴임박사
  • 자유와 이유
  • 커리어 코칭
  • 바이오테크
  • 보스턴 일상
  • 버킷리스트
  • 브런치 스토리

BIOTECH (103) Prime Medicine: Prime Editing

March 2, 2024March 2, 2024

BIOTECH (102) Elicio Therapeutics: Albumin-Hitchhiking Vaccine Amphiphile (AMP) Platform

March 1, 2024March 1, 2024

BIOTECH (101) Krystal Biotech: Redosable HSV-1 vector gene therapy – Vijuvek (beremagene geperpavec)

March 1, 2024March 1, 2024

BIOTECH (100) PureHealth Tech: Glyph – Lymphatic Delivery Platform

March 1, 2024March 1, 2024

BIOTECH (99) BlueRock Therapeutics: Bemdaneprocel (BRT-DA01, MSK-DA01) – Autologous Stem Cell Therapy for Parkinson’s Disease

March 1, 2024March 1, 2024

BIOTECH (98) Basking Biosciences: Bruce Sullenger’s Reversable RNA Aptamer Platform

March 1, 2024March 1, 2024

BIOTECH (97) Tome Biosciences: Programmable Genomic Integration (PGI) Platform

February 29, 2024February 29, 2024

BIOTECH (96) – Janux Therapeutics: Tumor Activated Masked T-Cell Engager (TRACTr) Platform

February 29, 2024

BIOTECH (95) – Ikena Oncology – Rebranding and Restructuring from Discovery to Clinical Focus

February 23, 2024February 23, 2024

BIOTECH (94) – Inventiva Pharma: Lanifibranor, a pan-PPAR agonist MASH 치료제 NATIV Phase 3

February 22, 2024February 22, 2024

Posts navigation

Older posts
Newer posts
Website Powered by WordPress.com.
  • Subscribe Subscribed
    BOSTON DR LIM

    Have a WordPress.com account? Log in now.

  • BOSTON DR LIM
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar
Loading Comments...